BDBM515744 BDBM515747::US11053219, Example 163::US11731956, Example 200

SMILES CCC(=O)c1cnc(NC(=O)C2CC2)cc1Nc1nccc(-c2ncn(C)n2)c1OC

InChI Key InChIKey=ZRKHCJOUTWUZAT-UHFFFAOYSA-N

Data  2 IC50  12 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 14 hits for monomerid = 515744   

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd: <1nMAssay Description:DiscoverX's KINOMEscan™ is a popular platform for kinase profiling, frequently used in academic and industry witnessed by publications, ther...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd: <1nMAssay Description:Developed by DiscoverX, KINOMEscan employs proprietary active-site dependent competition binding assays to determine how compounds bind to kinases. K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd: <1nMAssay Description:Developed by DiscoverX, KINOMEscan employs proprietary active-site dependent competition binding assays to determine how compounds bind to kinases. K...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd: <1nMAssay Description:DiscoverX's KINOMEscan™ is a popular platform for kinase profiling, frequently used in academic and industry witnessed by publications, ther...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd: <100nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataIC50: 100nMAssay Description:Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as IFNalpha induced p-STAT5 levelMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed
TargetTyrosine-protein kinase JAK1(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd: <100nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd: <100nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd: <100nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd:  550nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd:  550nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd:  5.50E+3nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataKd:  5.50E+3nMAssay Description:Similar to the method for TYK2 JH2 binding described above, JAK1 JH2 and JAK2 JH1 domain binding assay was performed using DiscoverX's KINOMEscan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Esker Therapeutics

US Patent
LigandPNGBDBM515744(US11053219, Example 163 | BDBM515747 | US11731956,...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of TYK2 signal transduction pathway in human PBMC cells assessed as reduction in GM-CSF induced p-STAT5 levelMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2024
Entry Details
PubMed